Chronic administration of moxonidine suppresses sympathetic activation in a rat heart failure model
- 1 May 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 397 (1) , 113-120
- https://doi.org/10.1016/s0014-2999(00)00232-6
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Regulation of β-Adrenoceptors in a Rat Model of Cardiac Failure: Effect of PerindoprilJournal of Cardiovascular Pharmacology, 1998
- Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks atter acute myocardial infarction: The GISSI-3 trialJournal of the American College of Cardiology, 1996
- Chronic Aspirin Treatment Affects Collagen Deposition in Non-infarcted Myocardium During Remodeling after Coronary Artery Ligation in the RatJournal of Molecular and Cellular Cardiology, 1995
- Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)The Lancet, 1995
- The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial InfarctionNew England Journal of Medicine, 1995
- Factors involved in capillary growth in the heartMolecular and Cellular Biochemistry, 1995
- Selective Antihypertensive Action of Moxonidine Is Mediated Mainly by I1-Imidazoline Receptors in the Rostral Ventrolateral MedullaJournal of Cardiovascular Pharmacology, 1994
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Early and late effects of captopril treatment after large myocardial infarction in ratsJournal of the American College of Cardiology, 1990
- Scar thinning due to ibuprofen administration after experimental myocardial infarctionThe American Journal of Cardiology, 1983